Search

everythinglearnresearchcommunity

for

Search:↓

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Hormone therapy can improve mental health and quality of life for people with gender dysphoria, but long-term effects need more research.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

More research is needed on the health effects of hormone therapy for transgender and nonbinary people.

Patients with oral lichen planus or oral lichenoid reactions had worse cholesterol levels and a higher risk of obesity compared to healthy individuals.

Metabolic syndrome is more common in people with early-onset androgenic alopecia.

The document concludes that more research is needed to fully understand the causes of PCOS.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

A man developed heart problems after using a baldness treatment for 4 months, suggesting that people with heart issues should avoid this treatment.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.

Young adults with hair loss face higher risk of stiff arteries.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

Men with early balding may have hormonal imbalances similar to women with PCOS and could benefit from similar treatments.

Gray hair is caused by reduced melanin production or transfer issues, linked to aging and possibly health conditions, with treatments focusing on color camouflage.

Early hair loss common in Chinese males, linked to family history and smoking; early treatment advised.

Most people in Turkey start getting gray hair around 33 years old, with factors like age, education, hair loss, skin type, family history, and anxiety playing a role.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Early-onset hair loss in young males is linked to a higher risk of metabolic syndrome.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

Prediabetes may be a risk factor for hair loss.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

The shape and size of the placenta may help predict future health risks for both mother and child.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.